PFIZER INC Disposal Group, Including Discontinued Operation, Liabilities
PFIZER INC (PFE) had Disposal Group, Including Discontinued Operation, Liabilities of $0 as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Balance Sheet › Liabilities
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation · last filed 2020-02-27
- 2019-12-31: Disposal Group, Including Discontinued Operation, Liabilities $0.00.
- 2019-09-29: Disposal Group, Including Discontinued Operation, Liabilities $0.00.
- 2019-06-30: Disposal Group, Including Discontinued Operation, Liabilities $2.01B.
- 2019-03-31: Disposal Group, Including Discontinued Operation, Liabilities $1.94B.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities | Disposal Group, Including Discontinued Operation, Liabilities as first filed |
|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | |
| 2019-09-29 | $0.00 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.01B 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.94B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.89B 10-K · filed 2020-02-27 | |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 | |
| 2013-12-31 | $21.00M 10-K · filed 2014-02-28 | |
| 2013-09-29 | $21.00M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $21.00M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $1.44B 10-K · filed 2014-02-28 | $0.00 10-K · filed 2013-02-28 |
| 2012-09-30 | $1.41B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $1.30B 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $1.22B 10-K · filed 2013-02-28 | |
| 2011-07-03 | $181.00M 10-Q · filed 2011-08-11 | |
| 2011-04-03 | $182.00M 10-Q · filed 2011-05-12 | |
| 2010-12-31 | $151.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |